Author

Sheraz Markar 1

1 Imperial College London

Gastric subepithelial lesions: Minimal-invasive surgery as standard treatment!

Sheraz Markar

Health-Related Quality of Life following Hybrid Minimally Invasive vs. Open Esophagectomy for patients with Esophageal Cancer, analysis of a multicenter, open-label, randomized phase III controlled trial, the MIRO trial

Sheraz Markar, Christophe Mariette, Sandrine Dabakuyo-Yonli, Bernard Meunier, Denis Pezet, Denis Collet, Xavier D'Journo, Cecile Brigand, Thierry Perniceni, N. Carrère, Franck Bonnetain, Guillaume Piessen

Immunonutrition to improve the quality of life of upper gastrointestinal cancer patients undergoing neoadjuvant treatment prior to surgery (NEOIMMUNE): Double blind randomized controlled multi-center clinical trial

Sheraz Markar, Christophe Mariette, Guillaume Piessen

Initial assessment

Sheraz Markar

IS LOCAL ENDOSCOPIC RESECTION A VIABLE THERAPEUTIC OPTION FOR EARLY CLINICAL STAGE T1A AND T1B OESOPHAGEAL ADENOCARCINOMA? A PROPENSITY-MATCHED ANALYSIS

Sivesh Kamarajah, Alexander Phillips, George Hanna, Donald Low, Sheraz Markar

LAsting Symptoms after Esophageal Resection (LASER) - European Multi-center Cross-sectional Study

Sheraz Markar, Giovanni Zaninotto, Pernilla Lagergren, Carlo Castoro, Jessie Elliott, Fredrik Klevebro, Mark Ivo van Berge Henegouwen, Jeremy Huddy, rita alfieri, Marco Scarpa, Suzanne S. Gisbertz, Asif Johar, Richard Van Hillegersberg, J.P. Ruurda, John Findlay, Nick Maynard, Stefan Antonowicz, Conor Murphy, Manuel Pera;

Management of tracheal fistula

Sheraz Markar

Rising Star: Breath analysis for non-invasive diagnosis of gastro-intestinal cancer

Sheraz Markar

SURGEON AND HOSPITAL VOLUME OF GASTRECTOMY AND SURVIVAL IN GASTRIC ADENOCARCINOMA IN A POPULATION-BASED COHORT STUDY

Fredrik Mattsson, Johannes Asplund, Sheraz Markar, Magdalena Plecka-Östlund, Jesper Lagergren

Surgery: Still the only option!

Sheraz Markar

Item 1 - 10 / 10
1